Informations générales (source: ClinicalTrials.gov)
(COAGHEMO)
Observational
University Hospital, Brest (Voir sur ClinicalTrials)
mars 2015
29 juin 2024
The purpose of this study is to evaluate the INR value of hemodialyzed patient
coagulation state (prothrombin time) measured inside the therapeutical zone and thanks to
a portable monitor. The values obtained at the point of care will be compared to the
standard biological assessment.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHU Brest - 29200 - Brest - France | Yannick LE MEUR, MD PhD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Age > 18
- Haemodialyzed patient whose INR needs to be monitored
- Patient not objecting to participate in the study
- Age > 18
- Haemodialyzed patient whose INR needs to be monitored
- Patient not objecting to participate in the study